150 related articles for article (PubMed ID: 8614498)
1. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.
Filippi M; Yousry T; Campi A; Kandziora C; Colombo B; Voltz R; Martinelli V; Spuler S; Bressi S; Scotti G; Comi G
Neurology; 1996 Feb; 46(2):379-84. PubMed ID: 8614498
[TBL] [Abstract][Full Text] [Related]
2. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.
Filippi M; Capra R; Campi A; Colombo B; Prandini F; Marcianò N; Gasparotti R; Comi G
J Neurol Neurosurg Psychiatry; 1996 May; 60(5):526-30. PubMed ID: 8778257
[TBL] [Abstract][Full Text] [Related]
3. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis.
Filippi M; Campi A; Martinelli V; Colombo B; Yousry T; Canal N; Scotti G; Comi G
J Neurol Neurosurg Psychiatry; 1995 Nov; 59(5):540-4. PubMed ID: 8530944
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.
Silver NC; Good CD; Barker GJ; MacManus DG; Thompson AJ; Moseley IF; McDonald WI; Miller DH
Brain; 1997 Jul; 120 ( Pt 7)():1149-61. PubMed ID: 9236628
[TBL] [Abstract][Full Text] [Related]
5. Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans.
Rovaris M; Mastronardo G; Prandini F; Bastianello S; Comi G; Filippi M
J Neurol Sci; 1999 Apr; 164(2):148-52. PubMed ID: 10402026
[TBL] [Abstract][Full Text] [Related]
6. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.
Filippi M; Rovaris M; Capra R; Gasperini C; Yousry TA; Sormani MP; Prandini F; Horsfield MA; Martinelli V; Bastianello S; Kühne I; Pozzilli C; Comi G
Brain; 1998 Oct; 121 ( Pt 10)():2011-20. PubMed ID: 9798753
[TBL] [Abstract][Full Text] [Related]
7. Triple dose of gadolinium-DTPA increases the sensitivity of spinal cord MRI in detecting enhancing lesions in multiple sclerosis.
Yousry TA; Fesl G; Walther E; Voltz R; Filippi M
J Neurol Sci; 1998 Jun; 158(2):221-5. PubMed ID: 9702695
[TBL] [Abstract][Full Text] [Related]
8. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
Miller DH; Rudge P; Johnson G; Kendall BE; Macmanus DG; Moseley IF; Barnes D; McDonald WI
Brain; 1988 Aug; 111 ( Pt 4)():927-39. PubMed ID: 3401689
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis.
Gasperini C; Paolillo A; Rovaris M; Yousry TA; Capra R; Bastianello S; Filippi M
Magn Reson Imaging; 2000 Jul; 18(6):761-3. PubMed ID: 10930786
[TBL] [Abstract][Full Text] [Related]
10. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
Bastianello S; Pozzilli C; Bernardi S; Bozzao L; Fantozzi LM; Buttinelli C; Fieschi C
Neurology; 1990 Apr; 40(4):591-5. PubMed ID: 2320230
[TBL] [Abstract][Full Text] [Related]
11. Gadoteridol in multiple sclerosis patients. A comparison of single and triple dose with immediate vs. delayed imaging.
Wolansky LJ; Finden SG; Chang R; Conigliari M; Lee HJ; Shaderowsky PD; Cook SD
Clin Imaging; 1998; 22(6):385-92. PubMed ID: 9876905
[TBL] [Abstract][Full Text] [Related]
12. A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in primary progressive multiple sclerosis.
Filippi M; Rovaris M; Gasperini C; Capra R; Bastianello S; Kuhne I; Yousry TA
J Neuroimaging; 1998 Apr; 8(2):88-93. PubMed ID: 9557146
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.
Kermode AG; Tofts PS; Thompson AJ; MacManus DG; Rudge P; Kendall BE; Kingsley DP; Moseley IF; du Boulay EP; McDonald WI
Neurology; 1990 Feb; 40(2):229-35. PubMed ID: 2300240
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of delayed gadolinium-enhanced MRI in multiple sclerosis.
Filippi M; Yousry T; Rocca MA; Fesl G; Voltz R; Comi G
Acta Neurol Scand; 1997 Jun; 95(6):331-4. PubMed ID: 9228265
[TBL] [Abstract][Full Text] [Related]
15. Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose.
Yousry I; Filippi M; Walther E; Gasperini C; Capra R; Yousry TA
Magn Reson Imaging; 2000 Nov; 18(9):1183-6. PubMed ID: 11118774
[TBL] [Abstract][Full Text] [Related]
16. High-dose contrast-enhanced MRI in multiple sclerosis.
Koudriavtseva T; Pozzilli C; Di Biasi C; Iannilli M; Trasimeni G; Gasperini C; Argentino C; Gualdi GF
Neuroradiology; 1996 May; 38 Suppl 1():S5-9. PubMed ID: 8811671
[TBL] [Abstract][Full Text] [Related]
17. Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions.
van Waesberghe JH; Castelijns JA; Roser W; Silver N; Yousry T; Lycklama à Nijeholt GJ; Adèr HJ; Uitdehaag BM; Radue EW; Polman CH; Kappos L; Miller DH; Barkhof F
AJNR Am J Neuroradiol; 1997 Aug; 18(7):1279-85. PubMed ID: 9282855
[TBL] [Abstract][Full Text] [Related]
18. MRI evolution of new MS lesions enhancing after different doses of gadolinium.
Rovaris M; Mastronardo G; Gasperini C; Prandini F; Yousry TA; Filippi M
Acta Neurol Scand; 1998 Aug; 98(2):90-3. PubMed ID: 9724005
[TBL] [Abstract][Full Text] [Related]
19. Cumulative Dose of Macrocyclic Gadolinium-Based Contrast Agent Improves Detection of Enhancing Lesions in Patients with Multiple Sclerosis.
Rovira A; Auger C; Huerga E; Corral JF; Mitjana R; Sastre-Garriga J; Tintoré M; Montalban X
AJNR Am J Neuroradiol; 2017 Aug; 38(8):1486-1493. PubMed ID: 28619842
[TBL] [Abstract][Full Text] [Related]
20. A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis.
Silver NC; Good CD; Sormani MP; MacManus DG; Thompson AJ; Filippi M; Miller DH
J Neurol; 2001 Mar; 248(3):215-24. PubMed ID: 11355156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
